My LDL is "normal" but my cardiologist is recommending a statin. Why?

A cardiologist recommending statin therapy to a man with LDL-C of 100–130 mg/dL is likely considering: (1) ApoB above 80–90 mg/dL suggesting particle-count risk beyond what LDL-C captures; (2) Lp(a) above 50 mg/dL adding independent cardiovascular risk; (3) elevated hs-CRP above 2 mg/L combined with LDL below 130 mg/dL (the JUPITER trial indication, reduced cardiovascular events with statin in this exact population); (4) CAC score above 100, indicating established coronary plaque requiring risk reduction beyond lifestyle alone; or (5) elevated 10-year cardiovascular risk from other factors (Ridker et al., NEJM, 2008).

The JUPITER trial specifically demonstrated that men with LDL below 130 mg/dL but hs-CRP above 2 mg/L benefit significantly from rosuvastatin, establishing that inflammation, independent of LDL, is a treatable cardiovascular risk factor. If your cardiologist is recommending statins with "normal" LDL, ask specifically which of the above findings drove the recommendation, the clinical reasoning should be explicit.

Honesty Scale: Solid (1) for JUPITER trial findings and the multiple non-LDL indications for statin therapy.

What to do: Ask your cardiologist directly: "Which specific lab finding or risk factor is driving the statin recommendation?" A complete answer should reference at least one of the five factors above. If the answer is only "your LDL is borderline," request ApoB, Lp(a), hs-CRP, and CAC score before making the decision.

For the full picture, read The ApoB/Lp(a)/Lipids Deep Dive